Who Will Benefit from the Darunavir Single-Tablet Regimen for HIV?

Magda Opsomer, MD, reveals who will benefit from the darunavir single-tablet HIV regimen.

Magda Opsomer, MD, director and clinical leader of Infectious Diseases and Vaccines at Janssen Pharmaceutical Companies, Belgium, reveals who will benefit from the darunavir single-tablet HIV regimen.

Related Videos
View All
Related Content
© 2023 MJH Life Sciences

All rights reserved.